Inogen, Inc · NASDAQ:INGN

Inogen — Q1 2023 Earnings Presentation

9 slides from Inogen's earnings presentation, May 4, 2023

  1. Slide 1: Q1 2023 Supplemental Financial Information

    May 4, 2023 Q1 2023 Supplemental Financial Information

  2. Slide 2: Use of Non-GAAP Financial Measures

    Use of Non-GAAP Financial Measures Inogen has presented certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis for the three months ended March 31, 2023 and March 31, 2022, and for fiscal years ended December 31, 2022, December 31, 2021, and December 31, 2020. Manage

  3. Slide 3: Total Revenue and Constant Currency Revenue

    Total Revenue and Constant Currency Revenue Y/Y 2020 2021 2022 2023 Growth (in $ millions) Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 B2B domestic 27.6 21.6 23.1 24.2 96.4 30.7 27.6 22.8 10.3 91.4 5.1 11.2 42.5 27.2 86.0 12.6 146.7% B2B international 20.1 13.9 14.6 13.6 62.1 15.7 21.8 21.8 20.1

  4. Slide 4: Q1 2023 Results

    Q1 2023 Results Revenue by region and category Total by Category Q1 Revenue Year-Over-Year Change % of Total Revenue Business-to-business $12.6 million 146.7% 17.4% domestic sales Business-to-business $19.0 million (32.1)% 26.3% international sales Direct-to-consumer $24.3 million (29.2)% 33.7% dome

  5. Slide 5: Operating Expense and Net Loss

    Operating Expense and Net Loss (in thousands) Three months ended March 31, 2023 2022 Operating expense Research and development $ 5,344 $ 5,364 Sales and marketing 28,441 28,039 General and administrative 18,863 15,189 Total operating expense 52,648 48,592 Loss from operations (21,915) (13,586) Othe

  6. Slide 6: Reconciliation of GAAP to Non-GAAP: Adjusted EBITDA

    Reconciliation of GAAP to Non-GAAP Adjusted EBITDA (in thousands) Three months ended March 31, Non-GAAP EBITDA and Adjusted EBITDA 2023 2022 Net loss (GAAP) $ (20,349) $ (14,214) Non-GAAP adjustments: Interest income (1,525) (29) Provision for income taxes 196 224 Depreciation and amortization 4,086

  7. Slide 7: Reconciliation of GAAP to Non-GAAP: Adjusted Net Income (Loss)

    Reconciliation of GAAP to Non-GAAP Adjusted Net Income (Loss) (in thousands) Three months ended March 31, Net Loss Diluted EPS Non-GAAP Adjusted Net Loss and Diluted EPS 2023 2022 2023 2022 Financial Results (GAAP) $ (20,349) $ (14,214) $ (0.88) $ (0.62) Non-GAAP adjustments: Amortization of intangi

  8. Slide 8: Reconciliation of GAAP to Non-GAAP: Constant Currency

    Reconciliation of GAAP to Non-GAAP Constant Currency (in thousands) Three months ended March 31, Non-GAAP constant currency revenue 2023 2022 Business-to-business domestic sales $ 12,585 $ 5,101 Business-to-business international sales 18,972 27,941 Direct-to-consumer domestic sales 24,330 34,360 Re

  9. Slide 9: Improving lives through respiratory care

    Improving lives through respiratory care

Inogen — Q1 2023 Earnings Presentation on 6ix